Biosimilars

(Image: Getty/Ronniechua)

How the US-Mexico trade deal could impact the biologics market

By Ben Hargreaves

BioPharma-Reporter (BPR) discusses with Jennifer Fox (JF), co-chair of Brinks Gilson & Lione’s biopharma practice group, the provisional detail revealed from the US administration’s proposed trade deal with Mexico, and its potential impact on the...

Follow us

Products

View more

Webinars